Jing Zeng

Title: Jing Zeng: Innovator in Hemoglobin Research

Introduction

Jing Zeng is a prominent inventor based in Boston, MA, known for her groundbreaking work in the field of hemoglobin research. She has made significant contributions to the understanding and treatment of hemoglobinopathies, particularly through her innovative patent.

Latest Patents

Jing Zeng holds a patent titled "Targeting BCL11A distal regulatory elements with a CAS9-CAS9 fusion for fetal hemoglobin reinduction." This patent provides methods and compositions for increasing fetal hemoglobin levels in a cell by disrupting BCL11A expression at the genomic level. The invention aims to offer new avenues for the treatment of hemoglobinopathies by reinducing fetal hemoglobin levels.

Career Highlights

Throughout her career, Jing Zeng has worked with notable organizations, including Children's Medical Center Corporation and the University of Massachusetts. Her work in these institutions has allowed her to advance her research and collaborate with other experts in the field.

Collaborations

Jing has collaborated with esteemed colleagues such as Daniel E. Bauer and Scot Andrew Wolfe, contributing to the advancement of research in her area of expertise.

Conclusion

Jing Zeng's innovative work in hemoglobin research and her patent on fetal hemoglobin reinduction highlight her significant contributions to medical science. Her efforts continue to pave the way for new treatments for hemoglobinopathies, showcasing the impact of her research on healthcare.